Brett Gerstman, MD
Physical Medicine & Rehabilitation · Chatham, NJNPI 1760687636
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Nevro Corp. accounts for 62.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $52 and has fallen 65.6% since, to $18 in 2023. That places this record below the midpoint for physical medicine & rehabilitation clinicians in NJ, where the typical reported total is $187.
Across 4 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$51
- Abbott$18
- Biodelivery Sciences International, Inc.$13
What the payments were for
- Food & beverage$82100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 2 | $51 |
| Abbott | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
How this compares
$82 in reported general payments places this provider in the 35th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 81 | $72,694 |
| Fentanyl | 171 | $32,151 |
| Xtampza ErOxycodone Myristate | 33 | $22,663 |
| Oxycodone Hcl | 734 | $21,897 |
| NucyntaTapentadol Hcl | 12 | $19,527 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 538 | $16,245 |
| SomaCarisoprodol | 12 | $12,665 |
| Gabapentin | 608 | $11,371 |
| Morphine Sulfate ErMorphine Sulfate | 248 | $10,229 |
| MovantikNaloxegol Oxalate | 20 | $10,013 |
| Ms ContinMorphine Sulfate | 12 | $9,144 |
| Lidocaine | 47 | $6,654 |
| Hysingla ErHydrocodone Bitartrate | 12 | $6,230 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 217 | $5,815 |
| Hydromorphone Hcl | 136 | $4,666 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Chatham
- Steven EscaldiEdison$70K
- Yekyung KongWest Orange$61K
- Joseph IbrahimBayonne$50K
- Steven KirshblumWest Orange$47K
- Joseph ValenzaChester$29K
- Christine GreissEdison$28K
- Bianca MartinezManasquan$25K
- Jason SmithCedar Knolls$19K
- Sandeep RathiLakewood$14K
- Anand PooleriCamden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.